Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Boston Scientific (BSX)
NYSE:BSX
Holding BSX?
Track your performance easily
BSX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$48.35 - $82.10
Previous Close$81.79
Volume7.64M
Average Volume (3M)5.48M
Market Cap
$118.80B
Enterprise Value$126.69B
Total Cash (Recent Filing)$2.91B
Total Debt (Recent Filing)$10.57B
Price to Earnings (P/E)66.2
Beta0.77
Next Earnings
Oct 23, 2024EPS Estimate
$0.59Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.24
Shares Outstanding1,472,626,135
10 Day Avg. Volume4,180,674
30 Day Avg. Volume5,480,999
Standard Deviation0.06
R-Squared0.41
Alpha0.00208
Financial Highlights & Ratios
Price to Book (P/B)212.90
Price to Sales (P/S)7.80
Price to Cash Flow (P/CF)36.50
P/FCF Ratio41.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.32
Enterprise Value/Gross Profit12.80
Enterprise Value/Ebitda34.72
Forecast
1Y Price Target
$87.44Price Target Upside6.91% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering19
Boston Scientific News
PremiumCompany Announcements
Boston Scientific Appoints New Director and Expands BoardBulls Say, Bears Say
Bulls Say
Full-Year GuidanceFull-year organic sales growth guidance was meaningfully raised to +13-14% from +10-12%, pointing to the sustainability of the momentum for Farapulse, Watchman, and across the portfolio.
Product PortfolioThe company has a diverse product portfolio which reduces dependency on a single product line.
Revenue GrowthBSX is on track to deliver +13-14% revenue growth in FY24 and +70bps of Y/Y OM expansion, vs the company’s 8-10% FY24-26 guide and 150-bps of cumulative OM expansion.
Bears Say
Product CompetitionBoston Scientific's crown jewel Emblem S-ICD is now facing competition for the first time from Medtronic's Aurora EV-ICD.
Product PortfolioBoston Scientific still has gaps and weaknesses in its vascular portfolio, including aortic and cutting balloons, with many markets having equally good alternatives available.
Regulatory ApprovalBoston Scientific did not file an NTAP application for Farapulse as the company did not expect to secure FDA approval in time.
---
Ownership Overview
4.89% Insiders
30.92% Mutual Funds
37.52% Other Institutional Investors
26.67% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BSX FAQ
What was Boston Scientific’s price range in the past 12 months?
Boston Scientific lowest stock price was $48.35 and its highest was $82.09 in the past 12 months.
What is Boston Scientific’s market cap?
Currently, no data Available
When is Boston Scientific’s upcoming earnings report date?
Boston Scientific’s upcoming earnings report date is Oct 23, 2024 which is in 53 days.
How were Boston Scientific’s earnings last quarter?
Boston Scientific released its earnings results on Jul 24, 2024. The company reported $0.62 earnings per share for the quarter, beating the consensus estimate of $0.583 by $0.037.
Is Boston Scientific overvalued?
According to Wall Street analysts Boston Scientific’s price is currently Undervalued.
Does Boston Scientific pay dividends?
Boston Scientific does not currently pay dividends.
What is Boston Scientific’s EPS estimate?
Boston Scientific’s EPS estimate is $0.59.
How many shares outstanding does Boston Scientific have?
Boston Scientific has 1,472,626,100 shares outstanding.
What happened to Boston Scientific’s price movement after its last earnings report?
Boston Scientific reported an EPS of $0.62 in its last earnings report, beating expectations of $0.583. Following the earnings report the stock price went down -1.056%.
Which hedge fund is a major shareholder of Boston Scientific?
Among the largest hedge funds holding Boston Scientific’s share is PRIMECAP Management Co. It holds Boston Scientific’s shares valued at 3B.
---
Boston Scientific Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$87.44 (6.91% Upside)
$87.44 (6.91% Upside)
Blogger Sentiment
Bullish
BSX Sentiment 76%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Increased
By 724.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▲ 0.4%
Last 30 Days <0.1%
Last 30 Days <0.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
50.70%
12-Months-Change
Fundamentals
Return on Equity
9.46%
Trailing 12-Months
Asset Growth
10.44%
Trailing 12-Months
Company Description
Boston Scientific
Boston Scientific Corporation engages in the manufacturing of medical devices and products that are used in various interventional medical specialties worldwide. The company provides implantable devices including heart monitors, technologies for treating coronary artery disease and other cardiovascular disorders, and devices for diagnosing and treating gastrointestinal and pulmonary problems.
---
BSX Company Deck
---
BSX Earnings Call
Q2 2024
0:00 / 0:00
---
BSX Revenue Breakdown
61.93% Cardiovascular
38.08% MedSurg
---
BSX Stock 12 Month Forecast
Average Price Target
$87.44
▲(6.91% Upside)
Technical Analysis
Best Analysts Covering BSX
1 Year
1 Year Success Rate
20/20 ratings generated profit
1 Year Average Return
+30.09%
assigned a buy rating last month
Copying Shagun Singh Chadha's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +30.09% per trade.
---